The temporal evaluation of RAS mutation by liquid biopsy at progression after bevacizumab-based treatment in patients with metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: The temporal evaluation of RAS mutation by liquid biopsy at progression after bevacizumab-based treatment in patients with metastatic colorectal cancer.
Authors: Bilgetekin I; Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey. irembilgetekin@gmail.com.; Department of Internal Medicine, Faculty of Medicine, Uskudar University, Istanbul, Turkey. irembilgetekin@gmail.com., Demirci U; Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey. drumutdemirci@gmail.com., Yildirim HC; Department of Medical Oncology, Faculty of Medicine, Ege University, İzmir, Turkey., Dogan M; Department of Pathology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Karacin C; Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Onur İD; Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Basal FB; Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Esin E; Department of Medical Oncology, Acıbadem Bayındır Hospital, Ankara, Turkey., Ucar G; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Isak OA; Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey., Imamoglu I; Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey., Keskin GSY; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey., Erturk I; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey., Aktas BY; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Baytemur NK; Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey., Aydin K; Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey., Ozturk SC; Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey., Aksel B; Department of General Surgery, Etlik City Hospital, Ankara, Turkey., Karadurmus N; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey., Kandemir O; Department of Pathology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Yalcin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Oksuzoglu B; Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1699-3055
DOI:10.1007/s12094-026-04441-2